BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36130517)

  • 1. Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus.
    Rush SA; Brar G; Hsieh CL; Chautard E; Rainho-Tomko JN; Slade CD; Bricault CA; Kume A; Kearns J; Groppo R; Mundle ST; Zhang L; Casimiro D; Fu TM; DiNapoli JM; McLellan JS
    Cell Rep; 2022 Sep; 40(12):111399. PubMed ID: 36130517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of hMPV F-specific antibodies isolated from human memory B cells.
    Xiao X; Fridman A; Zhang L; Pristatsky P; Durr E; Minnier M; Tang A; Cox KS; Wen Z; Moore R; Tian D; Galli JD; Cosmi S; Eddins MJ; Sullivan NL; Yan X; Bett AJ; Su HP; Vora KA; Chen Z; Zhang L
    Nat Commun; 2022 May; 13(1):2546. PubMed ID: 35538099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope on the metapneumovirus fusion trimerization interface.
    Xiao X; Wen Z; Chen Q; Shipman JM; Kostas J; Reid JC; Warren C; Tang A; Luo B; O'Donnell G; Fridman A; Chen Z; Vora KA; Zhang L; Su H-P; Eddins MJ
    J Virol; 2023 Dec; 97(12):e0105223. PubMed ID: 38032197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
    Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
    J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
    Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins.
    Hsieh CL; Rush SA; Palomo C; Chou CW; Pickens W; Más V; McLellan JS
    Nat Commun; 2022 Mar; 13(1):1299. PubMed ID: 35288548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus.
    Ou L; Chen SJ; Teng IT; Yang L; Zhang B; Zhou T; Biju A; Cheng C; Kong WP; Morano NC; Stancofski ED; Todd JP; Tsybovsky Y; Wang S; Zheng CY; Mascola JR; Shapiro L; Woodward RA; Buchholz UJ; Kwong PD
    PLoS Pathog; 2023 Sep; 19(9):e1011584. PubMed ID: 37738240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
    Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
    MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein.
    Rappazzo CG; Hsieh CL; Rush SA; Esterman ES; Delgado T; Geoghegan JC; Wec AZ; Sakharkar M; Más V; McLellan JS; Walker LM
    Immunity; 2022 Sep; 55(9):1710-1724.e8. PubMed ID: 35944529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
    Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses.
    Stewart-Jones GBE; Gorman J; Ou L; Zhang B; Joyce MG; Yang L; Cheng C; Chuang GY; Foulds KE; Kong WP; Olia AS; Sastry M; Shen CH; Todd JP; Tsybovsky Y; Verardi R; Yang Y; Collins PL; Corti D; Lanzavecchia A; Scorpio DG; Mascola JR; Buchholz UJ; Kwong PD
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
    Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
    PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
    Kinder JT; Moncman CL; Barrett C; Jin H; Kallewaard N; Dutch RE
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody recognition of the Pneumovirus fusion protein trimer interface.
    Huang J; Diaz D; Mousa JJ
    PLoS Pathog; 2020 Oct; 16(10):e1008942. PubMed ID: 33035266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses.
    Mukhamedova M; Wrapp D; Shen CH; Gilman MSA; Ruckwardt TJ; Schramm CA; Ault L; Chang L; Derrien-Colemyn A; Lucas SAM; Ransier A; Darko S; Phung E; Wang L; Zhang Y; Rush SA; Madan B; Stewart-Jones GBE; Costner PJ; Holman LA; Hickman SP; Berkowitz NM; Doria-Rose NA; Morabito KM; DeKosky BJ; Gaudinski MR; Chen GL; Crank MC; Misasi J; Sullivan NJ; Douek DC; Kwong PD; Graham BS; McLellan JS; Mascola JR
    Immunity; 2021 Apr; 54(4):769-780.e6. PubMed ID: 33823129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis.
    Wei Y; Zhang Y; Cai H; Mirza AM; Iorio RM; Peeples ME; Niewiesk S; Li J
    J Virol; 2014 Apr; 88(8):4338-52. PubMed ID: 24478423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode.
    Wen X; Suryadevara N; Kose N; Liu J; Zhan X; Handal LS; Williamson LE; Trivette A; Carnahan RH; Jardetzky TS; Crowe JE
    Cell Host Microbe; 2023 Aug; 31(8):1288-1300.e6. PubMed ID: 37516111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric
    Olmedillas E; Cano O; Martínez I; Luque D; Terrón MC; McLellan JS; Melero JA; Más V
    EMBO Mol Med; 2018 Feb; 10(2):175-187. PubMed ID: 29217660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
    Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
    J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
    Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
    J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.